Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
Kristopher B DeatrickSamuel M GalvagnoMichael A MazzeffiDavid J KaczoroswkiDaniel L HerrRaymond RectorEric HochbergRonald P RabinowitzThomas M ScaleaJay MenakerPublished in: Perfusion (2019)
In this pilot study, a non-titrating, weight-based heparin infusion appears safe and as effective in preventing veno-venous extracorporeal membrane oxygenation circuit thrombotic complications as compared to a titration algorithm. Larger studies are needed to confirm these preliminary findings.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- end stage renal disease
- venous thromboembolism
- body mass index
- physical activity
- newly diagnosed
- chronic kidney disease
- weight loss
- machine learning
- weight gain
- prognostic factors
- atrial fibrillation
- peritoneal dialysis
- low dose
- risk factors
- body weight
- growth factor
- patient reported